Quote:
Originally Posted by GoinAllTheWay
What are they up to these days? I remember reading about the plant based vaccine and it seemed promising. Haven't heard anything from the in ages.
|
They released phase 3 data a couple of months ago which was pretty good (~75% against Delta), and are currently under review by Health Canada. Not sure if they've produced much of anything in terms of doses though (that's also Novavax's issue). The rate of adverse events was fairly high though; nothing serious in the trial, but generally the COVID vaccines that are less well tolerated in trials tend to also have higher rates of more serious adverse events in the real world. So it's not really clear where it fits in with the current vaccine landscape.
Probably the only thing that's going to really supplant mRNA vaccines in industrialized countries in the near term will be if Novavax can be shown to have fewer adverse events. If it can maintain mRNA level efficacy while eliminating myocarditis risk, it could be the best option for further doses. But who knows what will happen in the real world. 1 in 50-100K side effects like myocarditis won't show up in trials where only 15K people are vaccinated.